Chandipura Virus' Oncolytic Potential in Experimentally Induced Tumor in Mice.

Cancer therapy Chandipura virus Oncolytic virus

Journal

Intervirology
ISSN: 1423-0100
Titre abrégé: Intervirology
Pays: Switzerland
ID NLM: 0364265

Informations de publication

Date de publication:
15 Dec 2020
Historique:
received: 27 05 2020
accepted: 22 09 2020
entrez: 15 12 2020
pubmed: 16 12 2020
medline: 16 12 2020
Statut: aheadofprint

Résumé

Chandipura virus (CHPV) is a tropical pathogen, suggesting its involvement in childhood encephalitis syndrome in India. No reports are available in adult human beings for its pathogenicity. Similarly, in adult mice, the virus does not develop pathogenesis by parenteral route except for intracranial route of infection. The virus is remarkably nonpathogenic to adult immunocompromised nude mice. In vitro in tissue culture, the CHPV infects and kills many types of cells. All of these properties could qualify the CHPV to be a candidate virus for tumor therapy. To prove this, an experimentally induced tumor in a mouse was infected with live CHPV. The results showed that intra-tumoral injection reduced the volume of tumor and increased the longevity of the mice. The study concludes that the CHPV may be a safe tumor therapy virus. More precisely, the discovery of CHPV protein with oncolytic potential may lead to the development of novel drugs/therapeutics.

Identifiants

pubmed: 33321508
pii: 000512299
doi: 10.1159/000512299
doi:

Types de publication

News

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-4

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Anukumar Balakrishnan (A)

ICMR-National Institute of Virology-Kerala Unit, Govt.T.D.Medical College Hospital, Alappuzha, India, anukumar74@gmail.com.

Nikita Malik (N)

Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts, USA.

Classifications MeSH